Transplantation is often the best option for those experiencing organ failure, but these invasive procedures carry both short- and long-term risks. In vivo and ex vivo gene therapy and gene editing may offer solutions to pressing challenges associated with transplantation.
Download this poster from Drug Discovery News to explore how scientists are using CRISPR and other gene therapy strategies to prevent immune rejection in recipients, protect transplanted organs, and expand the donor organ pool.
